Sunday, March 15, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026
    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026
    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Telehealth in Turmoil: Can America Preserve Its Pandemic-Driven Progress?

As COVID-era policies expire, telehealth stands at a crossroads—facing regulatory, financial, and technological uncertainty that could derail its transformative potential.

Dr. Muhamad Aly Rifai by Dr. Muhamad Aly Rifai
April 9, 2025
in Trends
0

The COVID-19 pandemic served as a catalyst for the rapid adoption of telehealth services across the United States. As in-person medical consultations became challenging, both healthcare providers and patients turned to virtual platforms to maintain continuity of care. Telehealth, encompassing a range of services from routine check-ups to specialized consultations, experienced unprecedented growth during this period. However, as the immediate crisis waned, the sustainability and integration of telehealth into the broader healthcare system faced numerous challenges, leading to a reevaluation of its role in American medicine.

In the early stages of the pandemic, telehealth emerged as a vital tool to bridge the gap between patients and healthcare providers. Regulatory bodies, recognizing the necessity, temporarily relaxed restrictions to facilitate virtual care. This included adjustments in reimbursement policies and the suspension of certain requirements, such as the in-person evaluation mandate for prescribing controlled substances. These measures enabled a swift transition to telehealth platforms, ensuring that patients continued to receive essential medical services without exposing themselves to potential viral transmission.

Telepsychiatry: A Case Study in Rapid Implementation

Telepsychiatry, the provision of psychiatric services through telecommunication technologies, exemplifies the rapid integration of telehealth during the pandemic. Historically, telepsychiatry was primarily utilized to serve rural and underserved populations with limited access to mental health professionals. The pandemic, however, necessitated its expansion to a broader patient base. I have been an early adopter of telepsychiatry, after finding myself at the forefront of this transformation. It is noted that the pandemic shifted telepsychiatry from a supplementary service to a mainstream necessity, highlighting its potential to address the burgeoning mental health crisis exacerbated by the pandemic. 

Challenges Emerge Post-Pandemic

As the immediate threat of COVID-19 diminished, several challenges emerged that hindered the continued expansion of telehealth services:

Regulatory Uncertainty: The temporary waivers and relaxed regulations that facilitated the rapid adoption of telehealth during the pandemic began to expire. For instance, the Ryan Haight Act, enacted in 2008, requires an in-person evaluation before prescribing controlled substances via telemedicine. During the pandemic, this requirement was suspended, allowing for greater flexibility. However, as the public health emergency declarations ended, the reinstatement of such regulations created uncertainty among providers regarding the legality of continuing certain telehealth practices. 

Reimbursement Discrepancies: Inconsistent reimbursement policies across different payers and states posed significant barriers. While Medicare expanded coverage for telehealth services during the pandemic, the future of such reimbursements remained uncertain. A report highlighted that without congressional action, most telehealth visits would not be covered by Medicare in 2025, potentially limiting access for many patients. 

Technological Barriers: Despite advancements, technological challenges persisted. Issues such as poor internet connectivity, inadequate technical support, and user-unfriendly platforms hindered the effectiveness of telehealth services. A study found that 80% of providers indicated inadequate technical support, and many frequently encountered technical challenges, including inefficient system design and poor audio/visual quality. 

Licensure and Interstate Practice: The lack of uniform licensure policies across states complicated the provision of telehealth services, especially for providers aiming to offer care to patients in multiple states. This fragmentation created administrative burdens and limited the scalability of telehealth solutions. 

The Path Forward: Integrating Telehealth into Standard Care

To ensure that telehealth remains a viable component of the American healthcare system, several steps must be taken:

Regulatory Reforms: Policymakers need to establish clear and consistent regulations that support the integration of telehealth into routine care. This includes revisiting laws like the Ryan Haight Act to balance the need for controlled substance regulation with the benefits of telemedicine.

Standardized Reimbursement Policies: Creating uniform reimbursement frameworks across payers and states will incentivize providers to continue offering telehealth services. Ensuring that telehealth visits are reimbursed at parity with in-person visits can promote broader adoption.

Investment in Technology Infrastructure: Addressing technological barriers is crucial. Investments in broadband infrastructure, especially in rural areas, and the development of user-friendly telehealth platforms can enhance the patient and provider experience.

Interstate Licensure Compacts: Encouraging states to participate in licensure compacts can facilitate interstate telehealth practice, allowing providers to reach underserved populations more effectively.

Public Awareness and Education: Educating both providers and patients about the benefits and limitations of telehealth can promote its appropriate use. Training programs for providers can enhance their comfort with telehealth technologies, while patient education can alleviate apprehensions related to virtual care.

The pandemic underscored the potential of telehealth to enhance healthcare delivery in the United States. However, realizing this potential requires addressing the regulatory, financial, technological, and educational challenges that have emerged. By proactively tackling these issues, stakeholders can ensure that telehealth becomes a permanent and effective component of the healthcare landscape, rather than a temporary solution to a crisis.

ShareTweet
Dr. Muhamad Aly Rifai

Dr. Muhamad Aly Rifai

Muhamad Aly Rifai is a Syrian American internist, and psychiatrist. He is a clinician researcher known for describing the association between psychiatric disorders and hepatitis C. He co-authored a clinical report detailing the association between hepatitis C infection and psychiatric disorders.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

In this episode of the Daily Remedy Podcast, Tiffany Ryder discusses her insights on healthcare messaging, the impact of COVID-19 on patient trust, and the importance of transparency in health policy. She emphasizes the need for clear communication in the face of divisiveness and explores the complexities surrounding the estrogen debate. Additionally, Tiffany highlights positive developments in health policy and the necessity of effectively conveying these changes to the public.

Tiffany Ryder is a political commentator and public health policy thought leader who publishes the Substack newsletter Signal and Noise: https://signalandnoise.online/


Chapters

00:00 Introduction to Healthcare Conversations
02:58 Signal and Noise: Understanding Healthcare Communication
05:56 The Storytelling Problem in Healthcare
08:58 Navigating Political Divisiveness in Health Policy
11:55 The Role of Media in Health Policy
15:03 Bias in Health Reporting
17:56 Estrogen and Health Policy: A Case Study
24:00 Positive Developments in Health Policy
27:03 Looking Ahead: Future of Health Policy
31:49 Communicating Health Policy Effectively
The Impact of COVID-19 on Patient Trust
YouTube Video ujzgl7HDlsw
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • If the Wealthy Live to 120

    If the Wealthy Live to 120

    0 shares
    Share 0 Tweet 0
  • Medicine & Law Cannot Get Along

    0 shares
    Share 0 Tweet 0
  • Fighting Back: Why Physicians Must Speak Up

    0 shares
    Share 0 Tweet 0
  • Familiarity Biases

    0 shares
    Share 0 Tweet 0
  • We May Soon Have a Nitazene Crisis

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy